Identification of potent COVID-19 main protease (MPRO) inhibitors from flavonoids: in silico approach
Identification of potent COVID-19 main protease (MPRO) inhibitors from flavonoids
DOI:
https://doi.org/10.70066/jahm.v11i2.686Keywords:
Flavonoids, COVID-19, main protease, Molecular docking, MD simulationsAbstract
BackgroundThe scientific researches on COVID-19 pandemic topics are headed to an explosion of scientific literature. Despite these global efforts, the efficient treatment of patients is an in-progress challenge. Based on a meta-study of published evidences about the compounds and their botanic sources in the last six decades, we have identified two potential flavonoids with high binding capacity and possible drug candidates against Mpro.
Methods
AUTODOCK tools 1.5.6.LigPlot+ and Protein-ligand Interaction Profiler was used to visualize the binding interactions. ADMET and drug-likeness study of ligands was done using OSIRIS Property Explorer and admetSAR. MD simulation was performed to check the stability of the ligand-enzyme complexes using UNRES web server.
Results
14 Flavonoids having antiviral properties and 4 existing drugs were used as ligands to bind to the COVID-19 main protease. Out of these ligands, flavonoids procyanidin b2 and mangiferin showed high binding affinity with the Mpro having Docking affinity of -9.4 and -8.5kcal/mol respectively.
Conclusion
Our results propose that flavonoids such as Procyanidin b2 and mangiferin have a better binding affinity to Mpro of COVID-19 than hydroxyhloroquine, favipiravir and remdesivir. These compounds with good binding potency support the potential as starting points for therapeutics against COVID-19.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Seema Kalra, Anita Chauhan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.
